- Page 4 and 5: Pharmacy PracticeEdited byKevin M.G
- Page 6 and 7: ContentsForewordContributorsPreface
- Page 8: 32. Professional audit and clinical
- Page 12 and 13: ContributorsClaire AndersonThe Phar
- Page 14 and 15: LSE HealthLondon School of Economic
- Page 16 and 17: Department of Social Policy and Soc
- Page 18: Sally WykeDepartment of Community H
- Page 22: AcknowledgementsWe are indebted to
- Page 26 and 27: 1The Historical Context of Pharmacy
- Page 28 and 29: The historical context of pharmacy
- Page 30 and 31: The historical context of pharmacy
- Page 32 and 33: The historical context of pharmacy
- Page 34 and 35: The historical context of pharmacy
- Page 36 and 37: The historical context of pharmacy
- Page 38 and 39: The historical context of pharmacy
- Page 40 and 41: The historical context of pharmacy
- Page 42 and 43: The historical context of pharmacy
- Page 44 and 45: The historical context of pharmacy
- Page 46 and 47: The historical context of pharmacy
- Page 48 and 49: The historical context of pharmacy
- Page 50 and 51: The historical context of pharmacy
- Page 52 and 53:
The pharmacy workforce 29employed i
- Page 54 and 55:
The pharmacy workforce 31an impact
- Page 56 and 57:
The pharmacy workforce 33disadvanta
- Page 58 and 59:
The pharmacy workforce 35Table 2.3
- Page 60 and 61:
The pharmacy workforce 37bridge’)
- Page 62 and 63:
The pharmacy workforce 39Hassell, K
- Page 64:
The pharmacy workforce 41Question 3
- Page 67 and 68:
Pharmacy practice 44long establishe
- Page 69 and 70:
Pharmacy practice 46Information tra
- Page 71 and 72:
Pharmacy practice 48903-905.Barrett
- Page 74:
PART TWOInternational Dimensions of
- Page 77 and 78:
Pharmacy practice 54pharmacy curric
- Page 79 and 80:
Pharmacy practice 56one pharmacist)
- Page 81 and 82:
Pharmacy practice 58The services pr
- Page 83 and 84:
Ireland, Norway, Portugal, and the
- Page 85 and 86:
5Pharmacy in North AmericaJoaquima
- Page 87 and 88:
Pharmacy practice 64PHARMACEUTICALS
- Page 89 and 90:
Pharmacy practice 66have to face so
- Page 91 and 92:
Pharmacy practice 68The same drugs
- Page 93 and 94:
Pharmacy practice 70Question 4:•
- Page 95 and 96:
Pharmacy practice 72HEALTH IN DEVEL
- Page 97 and 98:
Pharmacy practice 74be targeted. Il
- Page 99 and 100:
Pharmacy practice 76drugs and reduc
- Page 101 and 102:
Pharmacy practice 78reports that th
- Page 103 and 104:
Pharmacy practice 80a role in the p
- Page 105 and 106:
Pharmacy practice 82population grou
- Page 107 and 108:
Pharmacy practice 84Counterfeit pro
- Page 109 and 110:
Pharmacy practice 86tablets are als
- Page 111 and 112:
Pharmacy practice 88World Health Or
- Page 114:
PART THREEHealth, Illness and Medic
- Page 117 and 118:
Pharmacy practice 94A further chang
- Page 119 and 120:
Pharmacy practice 96absorbate or as
- Page 121 and 122:
Pharmacy practice 98has identified
- Page 123 and 124:
Pharmacy practice 100if at all poss
- Page 125 and 126:
Pharmacy practice 102these reveal t
- Page 127 and 128:
Pharmacy practice 104be achieved am
- Page 129 and 130:
Pharmacy practice 106be emblematic
- Page 132 and 133:
8Inequalities in Health and Health
- Page 134 and 135:
Inequalities in health and health c
- Page 136 and 137:
Inequalities in health and health c
- Page 138 and 139:
Inequalities in health and health c
- Page 140 and 141:
Inequalities in health and health c
- Page 142 and 143:
Inequalities in health and health c
- Page 144 and 145:
Inequalities in health and health c
- Page 146 and 147:
Inequalities in health and health c
- Page 148 and 149:
The supply and consumption of over
- Page 150 and 151:
The supply and consumption of over
- Page 152 and 153:
The supply and consumption of over
- Page 154 and 155:
The supply and consumption of over
- Page 156:
The supply and consumption of over
- Page 159 and 160:
Pharmacy practice 136improving qual
- Page 161 and 162:
Pharmacy practice 138are dirty and
- Page 163 and 164:
Pharmacy practice 140information do
- Page 165 and 166:
Pharmacy practice 142• Would you
- Page 167 and 168:
Pharmacy practice 144• Target inf
- Page 169 and 170:
Pharmacy practice 146Berger, B. (19
- Page 171 and 172:
11Compliance, Adherence and Concord
- Page 173 and 174:
Pharmacy practice 150associated wit
- Page 175 and 176:
Pharmacy practice 152Socio-demograp
- Page 177 and 178:
Pharmacy practice 154studies explor
- Page 179 and 180:
Pharmacy practice 156makes sense to
- Page 181 and 182:
Pharmacy practice 158Study 2: The f
- Page 183 and 184:
Pharmacy practice 160Box 11.7 Key p
- Page 185 and 186:
Pharmacy practice 162CONCLUSIONNona
- Page 187 and 188:
Pharmacy practice 164Gibbs, S., Wat
- Page 189 and 190:
Pharmacy practice 166Question 2: Th
- Page 192 and 193:
12Pharmacy as a ProfessionGeoffrey
- Page 194 and 195:
Pharmacy as a profession 171Figure
- Page 196 and 197:
Pharmacy as a profession 173the qua
- Page 198 and 199:
Pharmacy as a profession 175Constra
- Page 200 and 201:
Pharmacy as a profession 177evidenc
- Page 202 and 203:
Pharmacy as a profession 179Promoti
- Page 204 and 205:
Pharmacy as a profession 181MacDona
- Page 206 and 207:
Pharmacy as a profession 183permitt
- Page 208 and 209:
Professional judgement and ethical
- Page 210 and 211:
Professional judgement and ethical
- Page 212 and 213:
Professional judgement and ethical
- Page 214 and 215:
Professional judgement and ethical
- Page 216 and 217:
Professional judgement and ethical
- Page 218 and 219:
Professional judgement and ethical
- Page 220 and 221:
Professional judgement and ethical
- Page 222 and 223:
Professional judgement and ethical
- Page 224 and 225:
Professional judgement and ethical
- Page 226 and 227:
Professional judgement and ethical
- Page 228 and 229:
Professional judgement and ethical
- Page 230 and 231:
14Effective CommunicationNorman Mor
- Page 232 and 233:
Effective communication 209their vi
- Page 234 and 235:
Effective communication 211• Prac
- Page 236 and 237:
Effective communication 213ii Tone
- Page 238 and 239:
Effective communication 215• Give
- Page 240 and 241:
Effective communication 217• Stru
- Page 242 and 243:
Effective communication 219it just
- Page 244 and 245:
Effective communication 221Assertiv
- Page 246 and 247:
Effective communication 223Engage f
- Page 248 and 249:
Effective communication 225Hearing
- Page 250 and 251:
Effective communication 227Ross, P.
- Page 252 and 253:
15Pharmacists and the Multidiscipli
- Page 254 and 255:
Pharmacists and the multidisciplina
- Page 256 and 257:
Pharmacists and the multidisciplina
- Page 258 and 259:
Pharmacists and the multidisciplina
- Page 260 and 261:
Pharmacists and the multidisciplina
- Page 262 and 263:
Pharmacists and the multidisciplina
- Page 264 and 265:
Pharmacists and the multidisciplina
- Page 266 and 267:
Pharmacists and the multidisciplina
- Page 268 and 269:
Pharmacists and the multidisciplina
- Page 271:
PART FIVEMeeting the Pharmaceutical
- Page 274 and 275:
Ethnic minorities 251that we should
- Page 276 and 277:
Ethnic minorities 253traditional me
- Page 278 and 279:
Ethnic minorities 255Dual treatment
- Page 280 and 281:
Ethnic minorities 257Box 16.1 Probl
- Page 282 and 283:
Ethnic minorities 259Drug complianc
- Page 284 and 285:
Ethnic minorities 261Adherence with
- Page 286:
Ethnic minorities 263• Attitudes
- Page 289 and 290:
Pharmacy practice 266everyday life.
- Page 291 and 292:
Pharmacy practice 268• Self-medic
- Page 293 and 294:
Pharmacy practice 270different medi
- Page 295 and 296:
Pharmacy practice 272FURTHER READIN
- Page 298 and 299:
18Pregnancy and Breastfeeding Mothe
- Page 300 and 301:
Pregnancy and breastfeeding mothers
- Page 302 and 303:
Pregnancy and breastfeeding mothers
- Page 304 and 305:
Pregnancy and breastfeeding mothers
- Page 306 and 307:
Pregnancy and breastfeeding mothers
- Page 308 and 309:
Pregnancy and breastfeeding mothers
- Page 310 and 311:
The elderly and their carers 287•
- Page 312 and 313:
The elderly and their carers 289A s
- Page 314 and 315:
The elderly and their carers 291pat
- Page 316 and 317:
The elderly and their carers 293doc
- Page 318 and 319:
The elderly and their carers 295•
- Page 320 and 321:
The elderly and their carers 297evi
- Page 322 and 323:
The elderly and their carers 299Que
- Page 324 and 325:
20People with Mental Health Problem
- Page 326 and 327:
People with mental health problems
- Page 328 and 329:
People with mental health problems
- Page 330 and 331:
People with mental health problems
- Page 332 and 333:
People with mental health problems
- Page 334 and 335:
People with mental health problems
- Page 336 and 337:
People with mental health problems
- Page 338 and 339:
21Injecting Drug UsersJanie Sherida
- Page 340 and 341:
Injecting drug users 317HARM REDUCT
- Page 342 and 343:
Injecting drug users 319Table 21.3
- Page 344 and 345:
Injecting drug users 321• Avoid s
- Page 346 and 347:
Injecting drug users 323Oral.burns,
- Page 348 and 349:
Injecting drug users 325causes rais
- Page 350 and 351:
Injecting drug users 327Poor nutrit
- Page 352 and 353:
Injecting drug users 329reluctance
- Page 354 and 355:
Injecting drug users 331REFERENCESA
- Page 357:
PART SIXMeasuring and RegulatingMed
- Page 360 and 361:
Pharmacovigilance and pharmacoepide
- Page 362 and 363:
Pharmacovigilance and pharmacoepide
- Page 364 and 365:
Pharmacovigilance and pharmacoepide
- Page 366 and 367:
Pharmacovigilance and pharmacoepide
- Page 368 and 369:
Pharmacovigilance and pharmacoepide
- Page 370 and 371:
Pharmacovigilance and pharmacoepide
- Page 372 and 373:
Pharmacovigilance and pharmacoepide
- Page 374 and 375:
Pharmacovigilance and pharmacoepide
- Page 376 and 377:
Pharmacovigilance and pharmacoepide
- Page 378 and 379:
Pharmacovigilance and pharmacoepide
- Page 380 and 381:
Pharmacovigilance and pharmacoepide
- Page 383 and 384:
23Health EconomicsHakan BrodinINTRO
- Page 385 and 386:
Pharmacy practice 362• In the inc
- Page 387 and 388:
Pharmacy practice 364ECONOMIC EVALU
- Page 389 and 390:
Pharmacy practice 366Compared to th
- Page 391 and 392:
Pharmacy practice 368Cost-effective
- Page 393 and 394:
Pharmacy practice 370very longBox 2
- Page 395:
Pharmacy practice 372SELF-ASSESSMEN
- Page 399 and 400:
24Measurements of Health and Illnes
- Page 401 and 402:
Pharmacy practice 378is unlikely th
- Page 403 and 404:
Pharmacy practice 380time students,
- Page 405 and 406:
Pharmacy practice 382features of th
- Page 407 and 408:
Pharmacy practice 384review of cond
- Page 409 and 410:
Pharmacy practice 386impairments in
- Page 411 and 412:
Pharmacy practice 388data, inter-ra
- Page 413 and 414:
Pharmacy practice 390Alternative fo
- Page 415 and 416:
Pharmacy practice 392Hunt, S., McEw
- Page 417:
Pharmacy practice 394knowledge of t
- Page 420 and 421:
Survey methods 397diseases with whi
- Page 422 and 423:
Survey methods 399Evaluation• Use
- Page 424 and 425:
Survey methods 401‘rules’ gover
- Page 426 and 427:
Survey methods 403● Who you are;
- Page 428 and 429:
Survey methods 4057. Analysis8. Rep
- Page 430 and 431:
Survey methods 407expressions used
- Page 432 and 433:
Survey methods 409Table 25.2 Key co
- Page 434 and 435:
Survey methods 411The visual impact
- Page 436 and 437:
Survey methods 413nonresponse. Retu
- Page 438 and 439:
Survey methods 415advantages of a f
- Page 440 and 441:
Survey methods 417Halfpenny, P., Hu
- Page 442 and 443:
26InterviewsMadeleine GantleyINTROD
- Page 444 and 445:
Interviews 421have emerged in adapt
- Page 446 and 447:
Interviews 423of what happened last
- Page 448 and 449:
Interviews 425cosmetics?• The pla
- Page 450 and 451:
Interviews 427respondents, to provi
- Page 452 and 453:
Interviews 429Taking notesTaking br
- Page 454 and 455:
Interviews 431the generalisability
- Page 456 and 457:
Interviews 433Question 2: How would
- Page 458 and 459:
27Focus GroupsFelicity SmithINTRODU
- Page 460 and 461:
Focus groups 437objectives, either
- Page 462 and 463:
Focus groups 439● The group to fr
- Page 464 and 465:
Focus groups 441● What others iss
- Page 466:
Focus groups 443Smith, F.J. (1999)
- Page 469 and 470:
Pharmacy practice 446is generally l
- Page 471 and 472:
Pharmacy practice 448However, while
- Page 473 and 474:
Pharmacy practice 450REFERENCESLevi
- Page 475 and 476:
Pharmacy practice 452NominalNominal
- Page 477 and 478:
Pharmacy practice 454● It is deci
- Page 479 and 480:
Pharmacy practice 456n to give the
- Page 481 and 482:
Pharmacy practice 458assumptions an
- Page 483 and 484:
Pharmacy practice 460ANALYSIS OF VA
- Page 485 and 486:
Pharmacy practice 462explained by X
- Page 487:
Pharmacy practice 464Study 5. Level
- Page 490 and 491:
Evaluating community pharmacy servi
- Page 492 and 493:
Evaluating community pharmacy servi
- Page 494 and 495:
Evaluating community pharmacy servi
- Page 496 and 497:
Evaluating community pharmacy servi
- Page 498 and 499:
Evaluating community pharmacy servi
- Page 500 and 501:
Evaluating community pharmacy servi
- Page 502 and 503:
Evaluating hospital pharmacy servic
- Page 504 and 505:
Evaluating hospital pharmacy servic
- Page 506 and 507:
Evaluating hospital pharmacy servic
- Page 508 and 509:
Evaluating hospital pharmacy servic
- Page 510 and 511:
Evaluating hospital pharmacy servic
- Page 512:
Evaluating hospital pharmacy servic
- Page 515 and 516:
Pharmacy practice 492competence to
- Page 517 and 518:
Pharmacy practice 494THE AUDIT CYCL
- Page 519 and 520:
Pharmacy practice 496Inappropriate
- Page 521 and 522:
Pharmacy practice 498Institute for
- Page 523 and 524:
Pharmacy practice 500Howe, J. (1999
- Page 525 and 526:
IndexAbstracted empiricism 471Aches
- Page 527 and 528:
Index 504Cannabis 342Canon Medicina
- Page 529 and 530:
Index 506Confidence intervals 481Co
- Page 531 and 532:
symbolic transformation to medicine
- Page 533 and 534:
accessibility 515against standards
- Page 535 and 536:
Index 512models 435-436bio-medical
- Page 537 and 538:
Index 514Illness behaviour 107-9, 2
- Page 539 and 540:
Lay carers, see carersLay epidemiol
- Page 541 and 542:
developing countries 82-85ethnic mi
- Page 543 and 544:
Index 520confidentiality 377-378sat
- Page 545 and 546:
Index 522Pharmacy in a New Age (PIA
- Page 547 and 548:
Index 524Quality Adjusted Life Year
- Page 549 and 550:
Index 526ethical aspects 141-142leg
- Page 551 and 552:
follow-up 383randomised controlled
- Page 553:
Index 530World Wide Web 100, 205WWH